Atrium Therapeutics, Inc. (Nasdaq: RNA) in connection with its spin-off from Avidity Biosciences, as part of Avidity’s approximately $12 billion sale to Novartis AG.
Charter Communications, Inc. (Nasdaq: CHTR) in its:
- $4.75 billion senior notes offering.
- $5.5 billion debt exchange offers.
Eli Lilly and Company (NYSE: LLY) in its $7.8 billion acquisition of Centessa Pharmaceuticals (Nasdaq: CNTA).
Waters Corporation (NYSE: WAT) in connection with its $39 billion combination with Becton, Dickinson and Company’s (NYSE: BDX).